慢性前列腺炎的治療進展

1、 1.J. C. Nickel. Prostatitis: Evolving Management Strategies. Urol. Clin. North Am.: 1999, 26 (4): 737-751 2.Nickel JC.Prostatitis: lessons from the 20th century. BJU Int 2000 Jan;85(2):179-85 1.J. C. Nickel. Prostatitis: Evolving Management Strategies. Urol. Clin. North Am.: 1999, 26 (4): 737-751 2

2、.Nickel JC.Prostatitis: lessons from the 20th century. BJU Int 2000 Jan;85(2):179-85 1.J. C. Nickel. Prostatitis: Evolving Management Strategies. Urol. Clin. North Am.: 1999, 26 (4): 737-751 2.Nickel JC.Prostatitis: lessons from the 20th century. BJU Int 2000 Jan;85(2):179-85 Brunner H, Weidner W, S

3、chiefer HG. Studies of the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J Infect Dis 1983, 147: 807 Krieger, J. N., Nyberg, L., Jr. and Nickel, J. C.: NIH consensus definition and classification of prostatitis. JAMA, 282: 236,1999 Krieger, J. N., Nyberg, L., Jr. and Nickel,

4、J. C.: NIH consensus definition and classification of prostatitis. JAMA, 282: 236,1999 Krieger JN, Jacobs RR, Ross SO. Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J Urol 2000 Nov;164(5):1554-8 Potts JM. Prospective identification of Natio

5、nal Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000 Nov;164(5):1550-3 Potts JM. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000 Nov;164(5):1550-3 N

6、ickel JC, Nyberg LM, Hennenfent M.Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999 Aug;54(2):229-33 1.Nickel JC.Prostatitis: lessons from the 20th century. BJU Int 2000 Jan;85(2):1

7、79-85 2.Collins MM, Stafford RS, OLeary MP, et al. How common is prostatitis? A national survey of physician visits. J Urol. 1998, 159: 1224-8 3.Collins MM, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002 Mar;167(3):

8、1363-6 Collins MM, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002 Mar;167(3):1363-6 1.Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA.Prevalence of chronic prostatitis in men with premature ejaculat

9、ion. Urology 2001 Aug;58(2):198-202 2.Mehik A, Hellstrom P, Sarpola A, et al. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001 Jul;88(1):35-8 1.Wesselmann U. Neurogenic inflammation and chronic pelvic pain.

10、 World J Urol 2001 Jun;19(3):180-5 2.Shahed AR, Shoskes DA.Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl 2000 Sep-Oct;21(5):669-75 3.Pasqualotto FF, Sharma RK, Potts JM, et al. Semin

11、al oxidative stress in patients with chronic prostatitis. Urology 2000 Jun;55(6):881-5 4.Mehik A, Hellstrom P, Nickel JC, Kilponen A, et al. The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2002 Jan;167(1):137-40 1.John H, Ba

12、rghorn A, Funke G, et al. Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol 2001 Jan;39(1):72-8 2.Orhan I, Onur R, Ilhan N, Ardicoglu A. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol 2001

13、Sep;8(9):495-9 3.Nadler RB, Koch AE, Calhoun EA, et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000 Jul;164(1):214-8 4.Miller LJ, Fischer KA, Goralnick SJ, et al. Interleukin-10 levels in seminal plasma: implications fo

14、r chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002 Feb;167(2 Pt 1):753-6 5.Li LJ, Shen ZJ, Lu YL, Fu SZ. The value of endotoxin concentrations in expressed prostatic secretions for the diagnosis and classification of chronic prostatitis. BJU Int 2001 Oct;88(6):536-9 1.Krieger JN, Riley

15、DE, Vesella RL, et al. Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol 2000 Oct;164(4):1221-8 2.Hochreiter WW, Duncan JL, Schaeffer AJ.Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction

16、. J Urol 2000 Jan;163(1):127-30 3.Tanner MA, Shoskes D, Shahed A, Pace NR.Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and nonbacterial prostatitis. J Clin Microbiol 1999 Jun;37(6):1863-70 1.McNaughton Collins M, Pontari MA, et al. Quality of life is impaired in men wi

17、th chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001 Oct;16(10):656-62 2.Zernann DH, Ishigooka M, et al. The male chronic pelvic pain syndrome. World J Urol, 2001, 19: 173-179 J. C. Nickel. Prostatitis: Evolving Management Strategies. Urol. Clin. Nort

18、h Am.: 1999, 26 (4): 737-751 1.Shoskes DA.Use of antibiotics in chronic prostatitis syndromes. Can J Urol 2001 Jun;8 Suppl 1:24-8 2.Giannopoulos A, Koratzanis G, et al. P harmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis. J Urol 2001

19、Jan;165(1):97-9 3.Naber CK, Steghafner M, et al. Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers. Antimicrob Agents Chemother 2001 Jan;45(1):293-7 4.Drusa

20、no GL, Preston SL, Van Guilder M, et al. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother 2000 Aug;44(8):2046-51 Zermann DH, et al. The male chronic pelvic pain syndrome.World J Urol 2001 Jun;19(3):173-9 Quercetin（ 1.Gul O, Eroglu

21、M, Ozok U. Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Int Urol Nephrol 2001;32(3):433-6 2.Shoskes DA, Zeitlin SI, Shahed A, Rajfer J.Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind

22、, placebo-controlled trial. Urology 1999 Dec;54(6):960-3 3.Leskinen M, Lukkarinen O, Marttila T. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study. Urology 1999 Mar;53(3):502-5 4.Nickel JC, Johnston B, Downey J, et al. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial. Urology 2000 Sep 1;56(3):413 1.Habib FK. Ross M Buck. In vitro elaluation of the pollen extract cernitin T-60 in the regulation of pros